Last week, the market broke a five-week rally after a string of government reports painted a rosier picture of the economy than many had been predicting. That economic strength could justify more interest rate hikes and halt Wall Street’s year-end advance, said Bill Groenveld, header trader at vFinance Investments.

“Whether the market flattens out for the next couple of weeks, there’s always going to be uncertainty about the future,” Groenveld said. “It’s going to be a real news-sensitive market over the next quarter.”

The Dow Jones industrial average finished the day down 42.50 points, or 0.4 percent, while the broader Standard & Poor’s 500-stock index was down 2.99 points, or 0.2 percent. The Nasdaq composite index, full of technology stocks, dropped 15.73 points, or 0.7 percent.

Bond prices extended last week’s sell-off, with the yield on the 10-year Treasury note rising to 4.57 percent from 4.52 percent late Friday. The dollar declined against other major currencies, while gold prices continued climbing above $500 per ounce.

With little economic data expected this week, Wall Street will likely face several days of profit-taking following a month-long rally that boosted the Dow about 7 percent from its October lows, said Michael Sheldon, chief market strategist at Spencer Clarke LLC.

Sheldon said the market’s advance could be derailed entirely by escalating oil prices, higher yields on long-term bonds and indications that corporate earnings will fall short of expectations. “But until we see several days of significant selling and increased volume, we have to give the benefit of the doubt to the bulls,” Sheldon said.

The ISM said Monday that its non-manufacturing index pulled back to 58.5 in November from an October reading of 60. Economists thought service sector activity would slide to 59, but any level above 50 still implies growth.

Acquisitions led the day’s headlines. Boston Scientific Corp. launched a competing bid for rival Guidant of $25 billion, about $3.5 billion more than a recently reworked deal with Johnson & Johnson. The combined firm would be the world’s biggest maker of implantable heart devices. Guidant climbed $6.16 to $67.98, while Johnson & Johnson lost 16 cents to $61.05 and Boston Scientific fell 98 cents to $26.35.

Department store operator Sears Holdings Corp. has offered $718.5 million to buy up the remaining 46 percent of Sears Canada Inc. it doesn’t already own. The cash-for-stock deal is an 8.7 percent premium and would give Sears control of about 435 Canadian facilities. Sears was down $2.79 to $116.71.

Liberty Media Corp. has agreed to acquire Provide Commerce Inc., an online retailer of food and flowers, for $477 million, or $33.75 per share. Provide gained $3.53 to $33.76, and Liberty fell 3 cents to $7.77.

Intel Corp. sank 53 cents to $26.90 after revealing plans to spend more than $1 billion over the next five years to expand operations in India and invest in local technology companies.